The absence of chromosome 17 kataegis events co-localising with ERBB2 amplification in TCGA and ICGC PDAC tumours was further comparable with the molecular heterogeneity of PDAC [42] and suggests this phenomenon may only present in a small sub-population of patients. The gene discussed is ERBB2; the disease is neoplasm.